Embla Medical hf. (LON:0FIW)

Market Cap	1.46B -2.9%
Revenue (ttm)	741.98M +12.7%
Net Income	70.81M +28.5%
EPS	0.17 +27.2%
Shares Out	n/a
PE Ratio	20.55
Forward PE	18.33
Dividend	n/a
Ex-Dividend Date	n/a

Volume	7
Open	29.65
Previous Close	n/a
Day's Range	29.65 - 29.65
52-Week Range	25.90 - 36.40
Beta	0.58
Analysts	n/a
Price Target	n/a
Earnings Date	Jul 21, 2026

About Embla Medical

Embla Medical hf., together with its subsidiaries, provides non-invasive orthopedic products in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. It operates through three segments: Prosthetics and Neuro Orthotics, Bracing and Supports, and Patient Care. The Prosthetics and Neuro Orthotics segment offers mechanical products, such as lower and upper limb loss or difference; and bionic products, such as microprocessor-controlled feet, knees, hands, fingers, and neuro orthotic joints. The Bracing and Supports segment provides os...

• Industry: Orthopedic, Prosthetic, and Surgical Appliances and Supplies
• Founded: 1971
• Employees: 4,500
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0FIW

Financial Performance

In 2025, Embla Medical's revenue was $928.69 million, an increase of 8.63% compared to the previous year's $854.89 million. Earnings were $83.34 million, an increase of 22.05%.

Financial numbers in USD

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Aug 12, 2026

Data Sources Report a data error